Briefly, using the serial transplantation method, ATL cells derived from primary mice treated with the arsenic/IFN combination resulted in lower leukemia transplantation ability in untreated secondary mice and no transplantation in untreated tertiary mice (El Hajj et al., 2010). The gene discussed is IFNA1; the disease is leukemia.